Use of rhGM-CSF in Bone Marrow Failure
Radiation accidents resulting in significant injury are, fortunately, uncommon. However, one of the primary manifestations of radiation injury is bone marrow suppression. Depending on the dose of radiation and the manner in which it is received, hematologic effects can be acute and severe or chronic and delayed. The manifestations include aplastic anemia as well as increased risk of leukemia.
KeywordsAplastic Anemia Myelodysplastic Syndrome Paroxysmal Nocturnal Hemoglobinuria Intermittent Infusion Neutrophil Migration
Unable to display preview. Download preview PDF.
- 3.Esbach, J. W., Egrie, J. C., Downing, M. R., et al. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. N Engl J Med 316: 73–78, 1987.Google Scholar
- 7.Ganser, A., Volkers, B., Greher, J., et al. Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes: A phase I/II trial. Blood 73: 3137, 1989.Google Scholar
- 12.Brandt, S. J., Peters, W. P., Atwater, S. K., et al. Effect of human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. N Engl J Med 318: 869–876, 1988.Google Scholar
- 13.Neumunaitis, J., Singer, J. W., Buckner, C. D., et al. Use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous marrow transplantation for lymphoid malignancies. Blood 72: 834–836, 1988.Google Scholar
- 17.Antin, J. H., Weinberg, D. S., and Rosenthal, D. S. Variable effect of recombinant human granulocyte-macrophage colony-stimulating factor on bone marrow fibrosis in patients with myelodysplasia. Exp Hematol,in press.Google Scholar